BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han WH, Eom BW, Yoon HM, Reim D, Kim YW, Kim MS, Lee JM, Ryu KW. The optimal extent of lymph node dissection in gastroesophageal junctional cancer: retrospective case control study. BMC Cancer 2019;19:719. [PMID: 31331305 DOI: 10.1186/s12885-019-5922-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Chen X, He F, Chen M, Zhao F. Incidence of lymph node metastasis at each station in Siewert types Ⅱ/Ⅲ adenocarcinoma of the esophagogastric junction: A systematic review and meta-analysis. Surgical Oncology 2020;35:62-70. [DOI: 10.1016/j.suronc.2020.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Li Z, Jiang H, Chen J, Jiang Y, Liu Y, Xu L. Comparison of Efficacy Between Transabdominal and Transthoracic Surgical Approaches for Siewert Type II Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta-Analysis. Front Oncol 2022;12:813242. [DOI: 10.3389/fonc.2022.813242] [Reference Citation Analysis]
3 Imamura Y, Watanabe M, Oki E, Morita M, Baba H. Esophagogastric junction adenocarcinoma shares characteristics with gastric adenocarcinoma: Literature review and retrospective multicenter cohort study. Ann Gastroenterol Surg 2021;5:46-59. [PMID: 33532680 DOI: 10.1002/ags3.12406] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Kumar NA, Desouza A, Bhandare MS, Murugan JR, Khandelwal G, Chaudhari V, Ostwal V, Shrikhande SV. Curative resection for adenocarcinoma of the gastro-esophageal junction following neo-adjuvant chemotherapy-thoraco-abdominal vs. trans-abdominal approach. Langenbecks Arch Surg 2021;406:613-21. [PMID: 33242137 DOI: 10.1007/s00423-020-02020-9] [Reference Citation Analysis]